Advertisement
The company will host a conference call and live audio webcast at 9:00a.m. Eastern Time on the same day. During the conference call, ViroPharmamanagement will discuss the 2008 first quarter financial results and otherbusiness.
Advertisement
The press release and the live webcast of the conference call will beaccessible via ViroPharma's corporate website at http://www.viropharma.com.An audio archive will be available at the same address until May 14, 2008. Toparticipate in the conference call, please dial (877) 366-0713 (domestic) and(302) 607-2000 (international). After placing the call, please tell theoperator you wish to join the ViroPharma investor conference call.
About ViroPharma Incorporated
ViroPharma Incorporated is a biopharmaceutical company dedicated to thedevelopment and commercialization of products that address serious diseasestreated by physician specialists and in hospital settings. ViroPharmacommercializes Vancocin(R), approved for oral administration for treatment ofantibiotic-associated pseudomembranous colitis caused by Clostridium difficileand enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information, please download the packageinsert at http://www.viropharma.com/Products.aspx). ViroPharma currentlyfocuses its drug development activities in infectious diseases includingcytomegalovirus (CMV) and hepatitis C (HCV). For more information onViroPharma, visit the company's website at www.viropharma.com.
SOURCE ViroPharma Incorporated
